We reason that expression of genes bound by high levels of MEN1/MLL1 is also hypersensitive to MEN1 inhibition, which could underline the preferential toxicity of MEN1 inhibitor to EZH2 mutant lymphoma cell lines. This evidence concerns the gene EZH2 and lymphoma.